Differential CircRNA Expression Signatures May Serve as Potential Novel Biomarkers in Prostate Cancer

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Circular RNAs (circRNAs) are novel non-coding RNAs with regulatory functions.
• circRNAs have been detected in various cancers, including prostate cancer (PCa).
• Androgen receptor (AR) status is critical in PCa progression and treatment.

Purpose of the Study:

• To investigate the differential expression patterns of circRNAs in PCa.
• To explore the association between circRNA expression and AR status in PCa cell lines.
• To identify potential circRNA biomarkers for PCa diagnosis and prediction.

Main Methods:

• circRNA profiling using high-throughput microarray assay on nine prostate cell lines (normal, benign, malignant).
• Bioinformatic analysis to identify differentially expressed circRNAs and their parental genes.
• Grouped analysis based on androgen receptor (AR) status.

Main Results:

• More circRNAs were significantly up-regulated than down-regulated in malignant vs. benign PCa cell lines.
• Identified distinct circRNA expression signatures associated with androgen-dependent and independent PCa cell lines.
• Identified parental genes for top differentially expressed circRNAs, including RBMS3, SDC4, and Caprin1, with Caprin1 implicated in PCa survival and drug resistance.

Conclusions:

• circRNA expression profiles differ between malignant and benign prostate cells.
• circRNAs exhibit distinct expression patterns related to AR status, suggesting potential as androgen dependency markers.
• circRNAs, particularly those linked to Caprin1, represent promising candidates for future diagnostic and predictive biomarkers in PCa, warranting further validation.